Comorbidity in mental health in patients diagnosed with chronic obstructive pulmonary disease

被引:0
|
作者
Montserrat-Capdevila, J. [1 ,2 ,3 ]
Godoy, P. [2 ,3 ,4 ,5 ]
Marsal, J. R. [6 ]
Ortega, M. [1 ,7 ]
Pifarre, J. [2 ,3 ,8 ]
Barbe, F. [3 ,9 ,10 ]
机构
[1] Inst Catala Salut, Atenc Primaria, Lleida, Cataluna, Spain
[2] Inst Recerca Biomed Lleida IRBLleida, Lleida, Cataluna, Spain
[3] Univ Lleida, Fac Med, Lleida, Cataluna, Spain
[4] Agencia Salut Publ Catalunya, Dept Salut, Lleida, Cataluna, Spain
[5] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain
[6] Hosp Univ Vall dHebron, Unitat Epidemiol, Serv Cardiol, Barcelona, Cataluna, Spain
[7] Univ Autonoma Barcelona, Unitat Suport Recerca Lleida, Inst Univ Invest Atencio Primaria IDIAP Jordi Gol, Lleida, Cataluna, Spain
[8] Hosp Univ Santa Maria, Serv Psiquiatria, Lleida, Cataluna, Spain
[9] Inst Recerca Biomed Lleida IRBLleida, Grp Patol Resp, Lleida, Cataluna, Spain
[10] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain
来源
MEDICINA DE FAMILIA-SEMERGEN | 2020年 / 46卷 / 01期
关键词
Anxiety; Depression; Chronic obstructive pulmonary disease; Exacerbation; RISK-FACTORS; DEPRESSIVE SYMPTOMS; COPD EXACERBATIONS; FUNCTIONAL STATUS; ANXIETY; READMISSION; PREVALENCE; VALIDATION; DYSPNEA; BURDEN;
D O I
10.1016/j.semerg.2019.08.002
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: Anxiety and depression play an important role in chronic obstructive pulmonary disease, although there are a limited number of studies that have attempted to determine their relationship with exacerbations, and even less have tried to quantify the number of associated exacerbations. The aim of this study was to determine the risk of exacerbations associated with anxiety and depression in patients diagnosed with chronic obstructive pulmonary disease. Material and methods: A prospective cohort study was conducted that analysed the factors associated with exacerbations in 512 patients over a 2-year period. The exacerbations that required antibiotics and/or systemic corticosteroids were defined as moderate, and those that required hospital admission, as severe. The Hospital Anxiety and Depression Scale was applied to each patient, and the number of exacerbations during follow-up were quantified. Results: The prevalence of anxiety/depression at the beginning of the study was 15.6%. During the 2 years of follow-up, the mean number of exacerbations was 2.21. The patients that also had anxiety/depression at the beginning of the study had a higher mean number of exacerbations( 2.8; P = .001). Anxiety/depression was associated with an increased number of moderate-severe exacerbations in the adjusted analysis (IRRa = 1.48). The other risk factors associated with a higher mean number of exacerbations were, a history of a previous severe exacerbation( IRRa = 1.50; obesity (IRRa = 1.27); overweight (IRRa = 1.23); FEV1 <= 77% (IRRa = 0.84); and more dyspnoea (IRRa = 1.14). Conclusions: Patients with anxiety/depression have a greater number of exacerbations, and have a 48% higher risk of suffering an exacerbation compared to those with chronic obstructive pulmonary disease with no anxiety/depression. (C) 2019 Sociedad Espanola de Medicos de Atencion Primaria (SEMERGEN). Published by ElsevierEspa na, S.L.U. All rights reserved.
引用
收藏
页码:53 / 59
页数:7
相关论文
共 50 条
  • [1] Polypharmacy and Comorbidity in Patients With Chronic Obstructive Pulmonary Disease
    Fernandez-Lahera, Juan
    Verdasco, Antonio Martinez
    Bujarrabal, Jaime Fernandez
    Mendieta, Antonia
    Santiago, Ana
    Villasante, Carlos
    CHEST, 2013, 144 (04)
  • [2] Mental health in chronic obstructive pulmonary disease
    Mathioudakis, A. G.
    Amanetopoulou, S. G.
    Giannakopoulou, K.
    Alimani, G. S.
    Evangelopoulou, E., I
    Mathioudakis, G. A.
    ARCHIVES OF HELLENIC MEDICINE, 2019, 36 (02): : 186 - 194
  • [3] PREVALENCE OF COMORBIDITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Carlos Pedrozo-Pupo, John
    Campo-Arias, Adalberto
    De La Torre, Hector
    DUAZARY, 2018, 15 (03) : 273 - 280
  • [4] Comorbidity in chronic obstructive pulmonary disease
    Karoli, N. A.
    Orlova, E. E.
    Markova, A. V.
    Rebrova, A. P.
    TERAPEVTICHESKII ARKHIV, 2008, 80 (03) : 20 - 23
  • [5] Comorbidity in chronic obstructive pulmonary disease
    Negewo, Netsanet A.
    McDonald, Vanessa M.
    Gibson, Peter G.
    RESPIRATORY INVESTIGATION, 2015, 53 (06) : 249 - 258
  • [6] Assessment of Health Status in Patients with Newly Diagnosed Chronic Obstructive Pulmonary Disease
    Gao, Yongping
    Hou, Qi
    Wang, Haoyan
    PLOS ONE, 2013, 8 (12):
  • [7] Comorbidity in patients with chronic obstructive pulmonary disease and its influence
    Apps, MCP
    Ahmed, R
    Jubber, AS
    Weatherstone, RM
    Fowler, RW
    THORAX, 2005, 60 : II70 - II70
  • [8] Cardiovascular comorbidity and mortality in patients with chronic obstructive pulmonary disease
    Pavlov, Plamen
    Ivanov, Yavor
    Glogovska, Pavlina
    Popova, Tsania
    Borisova, Elena
    Nozharov, Venzislav
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [9] Chronic Obstructive Pulmonary Disease and Pulmonary Vascular Disease A Comorbidity?
    Weissmann, Norbert
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2018, 15 : S278 - S281
  • [10] Comorbidity: pulmonary tuberculosis and chronic obstructive pulmonary disease
    Jakimova, Marina Artemovna
    Karpina, Natalya
    Gordeeva, Olga
    Asanov, Rasul
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54